Leicher Bruce 4
4 · MOMENTA PHARMACEUTICALS INC · Filed May 10, 2018
Insider Transaction Report
Form 4
Leicher Bruce
SVP & General Counsel
Transactions
- Exercise/Conversion
Common Stock
2018-05-08+1,345→ 172,188 total - Sale
Common Stock
2018-05-08$18.08/sh−471$8,516→ 171,717 total - Exercise/Conversion
Restricted Stock Units
2018-05-08−1,345→ 14,799 total→ Common Stock (1,345 underlying)
Footnotes (4)
- [F1]Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F3]Restricted Stock Units convert into common stock on a one-for-one basis.
- [F4]Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.